EndoCells Overview

  • Founded
  • 2004
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 5
Employees
  • Latest Deal Type
  • M&A

EndoCells General Information

Description

Developer of a novel proprietary pancreatic beta islet cell immortalization technology intended to focus on the generation and development of human endocrine cell lines. The company's technology platform allows the generation and development of human endocrine cell lines for drug screening and cell transplantation therapy of Type 1 diabetes, providing laboratories and industries with human beta cell lines for research, drug discovery, development and cell therapy.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Laboratory Services (Healthcare)
Primary Office
  • 216 Boulevard Saint Germain
  • 75007 Paris
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EndoCells Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Dec-2015 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view EndoCells’s complete valuation and funding history, request access »

EndoCells Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EndoCells Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Esperante Ventures Corporate Venture Capital Minority 000 0000 000000 0
To view EndoCells’s complete investors history, request access »